The prevalence of cancer in the population being tested has a direct impact on PPV. Higher prevalence rates typically result in higher PPV because the likelihood of a positive test indicating true disease increases. Conversely, in populations with low prevalence, the PPV is generally lower, meaning there is a higher chance of false positives. This relationship underscores the importance of selecting appropriate populations for screening programs.
